PublizoomAward notice Supplies
Raamovereenkomst voor het leveren van Cytostatica Oraal
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- Hospilim VZW
Diepenbeek - Place of performance
- 3590 Diepenbeek, Limburg
not published: buyer's address - Estimated value
- €11,000,000 excl. VAT
- Amount awarded
- €11,000,000 excl. VAT
- Planned end of contract
- 12 December 2027
likely re-tender around June 2027 - Bids received
- 2
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 29 January 2024
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Raamovereenkomst voor het leveren van Cytostatica Oraal Ref.: 2023-HospiLim-107
Awarded to
17 lots
- Abirateron
- Anagrelide
- Capecitabine
- Cladribine Oraal
- Cyclofosfamide Oraal
- Dasatinib oraal 10 mg / 1 ml
- Dasatinib
- Enzalutamide
- Etoposide Oraal 50 mg
- Etoposide Oraal 100 mg
- Everolimus
- Methotrexaat Oraal
- Sorafenib 200 mg
- Sorafenib 400 mg
- Sunitinib
- Temozolomide Oraal
- Topotecan Oraal
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst voor de levering van contrastmiddelen Hospilim VZW · 5 May 2026 |
Bayer GE HEALTHCARE Bracco Imaging Europe GUERBET |
€22,614,392 |
| Totale Parenterale Nutritie (TPN) Mini Competitie JESSA-NH-STZH-SFZ Hospilim VZW · 30 September 2024 |
Baxter Belgium srl Fresenius Kabi NV |
– |
| Totale Parentale Nutritie (TPN) Mini competitie ZOL-AZV Hospilim VZW · 6 June 2024 |
Fresenius Kabi NV | – |
| Raamovereenkomst voor het leveren van Cytostatica Parenteraal Hospilim VZW · 26 January 2024 |
Roche NV Accord Healthcare BV Celltrion Healthcare Netherlands BV Pharmanovia Benelux BV Viatris BV Fresenius Kabi NV Baxter Belgium SRL Aurobindo NV AstraZeneca NV Arega Pharma BV Servier Benelux NV MSD Belgium BV Sandoz NV |
€375,000,000 |
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 58104-2024.